Catalyst Capital Advisors LLC

Position in LLY — ELI LILLY & Co

CIK 1549275 San Juan, PR

Position in LLY

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$731,652

-$1,544,778 QoQ

Shares Held

610

-75.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#3,418

of 4,621 holders

Holding Since

Mar 2020

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Catalyst Capital Advisors LLC holds $11,881,964 across 6 Drug Manufacturers - General names. LLY ranks #4 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	41,842	$6,557,477
2	SNY	Sanofi	79,028	$3,371,334
3	JNJ	Johnson & Johnson	4,438	$1,127,118
4	LLY	ELI LILLY & Co This page	610	$731,652
5	AMGN	Amgen Inc	149	$53,955
6	GILD	Gilead Sciences, Inc.	320	$40,428

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$731,652	610	-75.4%	Shares	Sole	2026-07-24
2026-03-31	$2,276,430	2,475	-93.8%	Shares	Other	2026-05-06
2020-09-30	$5,891,196	39,800	-5.5%	Shares	Other	2020-11-05
2020-06-30	$6,911,978	42,100	-8.5%	Shares	Other	2020-08-10
2020-03-31	$6,381,120	46,000	—	Shares	Other	2020-05-12
No filing history on record for this holder in this stock.